Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer.
Ayodeji O OlukoyaHillary S AndrewsShaymaa BahnassySonali PersaudYanira GuerraSuman RanjitShihong MaM Idalia CruzCarlos BenitezAaron M RozeboomHannah CeuleersDeborah L BerryBritta M JacobsenGanesh V RajRebecca B RigginsPublished in: Journal of the Endocrine Society (2023)
Riluzole may offer therapeutic benefits in diverse ER+ breast cancers, including lobular breast cancer.